MAPT and Alzheimer disease: In tau mouse models of AD, expression of APOE4 has been shown to exacerbate tau-mediated neurodegeneration compared to mice with APOE3 expression, while the selective removal of astrocytic APOE4 is protective (Wang et al., 2021).